Healthcare AI company Innovaccer Inc. has raised $275 million in a Series F funding round, comprising both essential and secondary investments. The circular included interest from B Capital Group, Banner Health, Danaher Ventures LLC, Era Investment Management, Kaiser Permanente, and M12.

The Noida and San Francisco-based company has raised stores after a gap of more than three a long time. In December 2021, it secured $150 million in Arrangement E financing. To date, it has raised $675 million and is as of now esteemed at over $3.4 billion.

This new investment will fuel Innovaccer’s endeavors to extend its collaboration with existing clients, present modern AI and cloud capabilities, and scale a developer ecosystem on the stage, the company said in a press release. Innovaccer moreover plans to include different copilots and operators to its offerings, counting utilization administration, earlier authorization, clinical decision support, clinical documentation, care administration, and contact center services.

Founded in 2014, Innovaccer makes a difference healthcare organizations by giving a comprehensive suite of program arrangements to control value-based care programs, modernize the persistent encounter, and diminish the authoritative burden on suppliers. 

According to the company, it has achieved Best-in-KLAS acknowledgment over numerous categories, counting information and analytics, population health management, and CRM.

It presently serves six of the top 10 health systems in the US and has strengthened public sector partnerships with San Mateo Province and Alameda Province. The stage bolsters over 130 healthcare organizations and has accomplished 50% year-on-year income development for the past five years.

While Innovaccer did not uncover its most recent financials, the firm was anticipating turning productive in the to begin with two quarters of FY25. In India, it recorded Rs 397 crore in income and Rs 37 crore in benefit in FY23. It has however to record yearly money related reports for FY24.

Over the past year, the Abhinav Shashank-led firm too procured two companies—Cured and Pharmacy Quality Solutions—to upgrade its capabilities

source: entrackr.